Inhibrx Biosciences Inc.
INBX | NASDAQ
$114.39
+$2.35 (+2.10%)
Sep 22, 2026, 10:57 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 1.3M | n/a | 100K | n/a | 100K | n/a | 1.63M | 119K | 30K | 17K | 274K | 278K | 711K | 915K | 2.84M | 2.53M | 954K | 863K |
Cost of Revenue | n/a | 537K | 564K | 582K | 662K | 675K | 689K | 760K | n/a | 360K | 298K | 304K | 295K | 294K | 720K | 719K | 708K | 699K | 692K | 676K | n/a | 16.44M |
Gross Profit | n/a | -537K | -564K | -582K | 638K | -675K | -589K | -760K | 100K | -360K | 1.34M | -185K | -265K | -277K | -446K | -441K | 3K | 915K | 2.84M | 1.86M | 954K | -15.58M |
Operating Income | -32.15M | -30.93M | -30.92M | -33.81M | -27.39M | -42.9M | -49.93M | -46.8M | -160.9M | -73.83M | -88.29M | -45.83M | -41.34M | -43.77M | -35.5M | -30M | -34.6M | -29.02M | -19.4M | -18.8M | -19.8M | -18.56M |
Interest Income | 1.26M | 1.01M | 1.31M | 1.78M | 2.12M | 2.33M | 2M | 2.89M | 2.74M | 3.3M | 4.7M | 2.32M | 2.41M | 5.08M | 5.35M | 5.34M | 3.15M | n/a | n/a | n/a | n/a | 745K |
Pretax Income | -36.65M | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -93.61M | -51.79M | -47.05M | -48.92M | -40.92M | -35.33M | -37.73M | -31.25M | -21.19M | -20.58M | -20.71M | -19.29M |
Net Income | -36.65M | -33.44M | -32.83M | -35.26M | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -93.6M | -51.79M | -47.05M | -48.69M | -40.92M | -40.65M | -37.73M | -33.49M | -21.19M | -20.58M | -20.71M | -19.29M |
Selling & General & Admin | 8.25M | 5.7M | 5.57M | 5.28M | 6.42M | 6.02M | 16.66M | 7.8M | 93.37M | 9.87M | 7.79M | 7.89M | 7.21M | 6.4M | 5.32M | 5.35M | 5.4M | 5.05M | 3.65M | 2.85M | 2.85M | 3.01M |
Research & Development | 23.9M | 24.69M | 25.35M | 28.54M | 22.27M | 36.88M | 33.37M | 38.23M | 67.63M | 63.6M | 81.84M | 38.06M | 33.86M | 37.15M | 30.45M | 24.93M | 29.91M | 24.9M | 18.62M | 18.49M | 17.9M | 16.44M |
Other Expenses | n/a | n/a | -564K | -582K | -662K | -675K | -689K | n/a | n/a | n/a | n/a | -304K | n/a | -57K | -720K | -719K | -708K | -14K | -20K | -676K | n/a | -16.45M |
Operating Expenses | 32.15M | 30.39M | 30.36M | 33.23M | 28.03M | 42.23M | 49.34M | 46.04M | 161M | 73.47M | 89.63M | 45.64M | 41.07M | 43.49M | 35.05M | 29.56M | 34.6M | 29.93M | 22.24M | 20.66M | 20.76M | 2.99M |
Interest Expense | 5.69M | 3.51M | 3.19M | 3.18M | 3.14M | 2.69M | n/a | n/a | 5.36M | 8.13M | 8.22M | 8.15M | 7.91M | 5.08M | 5.35M | 5.34M | 3.15M | 2.27M | 1.78M | 1.78M | 914K | 745K |
Selling & Marketing Expenses | n/a | -7K | n/a | n/a | n/a | n/a | n/a | -100K | n/a | -104K | -46K | n/a | -53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.15M | 30.93M | 30.92M | 33.81M | 28.69M | 42.9M | 50.03M | 46.8M | 161M | 73.83M | 89.92M | 45.95M | 41.37M | 43.78M | 35.77M | 30.28M | 35.31M | 29.93M | 22.24M | 21.31M | 20.76M | 19.42M |
Income Tax Expense | 3K | n/a | n/a | n/a | 2K | n/a | n/a | n/a | 2K | n/a | -4K | 2K | 5K | n/a | -1K | 5.32M | 4K | 2.24M | n/a | n/a | n/a | 2K |
Shares Outstanding (Basic) | 15.67M | 15.59M | 15.49M | 15.48M | 15.47M | 15.47M | 14.48M | 15.47M | 14.62M | 54.55M | 54.04M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M | 37.74M |
Shares Outstanding (Diluted) | 15.67M | 15.59M | 15.49M | 15.48M | 15.47M | 15.47M | 14.48M | 15.47M | 14.81M | 54.55M | 54.04M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M | 37.74M |
EPS (Basic) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.31 | -2.84 | 127.10 | -1.44 | -1.73 | -1.10 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 | -0.51 |
EPS (Diluted) | -2.34 | -2.15 | -2.11 | -2.28 | -1.85 | -2.80 | -3.31 | -2.84 | 125.48 | -1.44 | -1.73 | -1.10 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 | -0.51 |
EBITDA | -30.48M | -29.4M | -29.09M | -31.49M | -24.85M | -39.95M | -47.18M | -43.1M | 1.86B | -70.22M | -87.99M | -43.33M | -38.85M | -41.06M | -35.2M | -29.69M | -34.27M | -28.67M | -19.1M | -18.5M | -19.8M | -18.25M |
EBIT | -31M | -29.93M | -29.65M | -32.08M | -25.51M | -40.62M | -47.87M | -43.86M | 1.86B | -70.58M | -88.29M | -43.64M | -39.14M | -41.35M | -35.57M | -29.99M | -34.58M | -28.98M | -19.41M | -18.8M | -19.8M | -18.54M |
Depreciation & Amortization | 523K | 537K | 564K | 583K | 661K | 675K | 689K | 760K | n/a | 360K | 298K | 304K | 295K | 295K | 302K | 309K | 324K | 344K | 307K | 299K | n/a | 291K |
Add to Watchlist
Select watchlists to add or remove INBX